Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 3.4800
- +0.0100+0.29%
Close Dec 13 16:00 ET
- 3.6000
- +0.1200+3.45%
Post 20:01 ET
235.20MMarket Cap-2.34P/E (TTM)
3.5900High3.2700Low1.35MVolume3.4800Open3.4700Pre Close4.64MTurnover3.04%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.72P/B154.88MFloat Cap2.521052wk Low--Dividend TTM44.51MShs Float85.0000Historical High--Div YieldTTM9.22%Amplitude0.0300Historical Low3.4260Avg Price1Lot Size
Perspective Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -64.67%3.55M | -7.56%2.51M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -64.67%3.55M | -7.56%2.51M |
| Cost of revenue | -44.55%2.74M | 15.76%1.58M | ||||||||
| Gross profit | -84.05%817K | -31.20%926K | ||||||||
| Operating expense | 91.12%18.63M | 46.23%14.26M | 33.54%13.01M | 386.93%40.94M | 285.82%11.7M | 246.11%9.75M | 9.75M | 9.74M | -1.75%8.41M | 24.31%3.03M |
| Selling and administrative expenses | 55.90%6.98M | 10.57%5.51M | -11.78%5.88M | 196.38%21.06M | 120.93%4.94M | 97.27%4.47M | --4.99M | --6.66M | -0.34%7.11M | 13.44%2.24M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -34.46%1.57M | -0.49%607K |
| -General and administrative expense | 55.90%6.98M | 10.57%5.51M | -11.78%5.88M | 280.22%21.06M | 203.25%4.94M | 182.99%4.47M | --4.99M | --6.66M | 16.88%5.54M | 19.69%1.63M |
| Research and development costs | 116.64%12.03M | 72.72%9.28M | 125.20%7.45M | 1,538.05%21.31M | 789.45%7.08M | 911.29%5.55M | --5.37M | --3.31M | -8.83%1.3M | 70.09%796K |
| Other operating expenses | -33.70%-369K | 12.77%-526K | -39.48%-325K | ---1.43M | ---322K | ---276K | ---603K | ---233K | ---- | ---- |
| Operating profit | -91.12%-18.63M | -46.23%-14.26M | -33.54%-13.01M | -439.34%-40.94M | -455.46%-11.7M | -608.58%-9.75M | -9.75M | -9.74M | -120.86%-7.59M | -92.68%-2.11M |
| Net non-operating interest income expense | 1,748.42%3.51M | 1,039.18%3.05M | 232.02%1.18M | 51.52%850K | 28.57%36K | 555.17%190K | 268K | 356K | 850.85%561K | -12.50%28K |
| Non-operating interest income | 1,655.39%3.58M | 946.26%3.08M | 223.80%1.21M | 66.49%934K | 121.43%62K | 603.45%204K | --294K | --374K | 850.85%561K | -12.50%28K |
| Non-operating interest expense | 392.86%69K | -11.54%23K | 61.11%29K | --84K | --26K | --14K | --26K | --18K | ---- | ---- |
| Other net income (expense) | -4K | 90.91%-2K | 95.08%-15K | 19K | -12K | -22K | -3,288.89%-305K | |||
| Earnings from equity interest | --0 | ---4K | ---2K | ---17K | ---5K | ---12K | --0 | --0 | ---- | ---- |
| Special income (charges) | --0 | --0 | --0 | --0 | --22K | --0 | --0 | ---22K | -3,288.89%-305K | --0 |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | --0 | --22K | --0 | --0 | ---22K | -3,288.89%-305K | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -57.98%-15.12M | -18.22%-11.21M | -25.73%-11.83M | -446.78%-40.11M | -460.30%-11.64M | -610.62%-9.57M | -9.49M | -9.41M | -116.56%-7.34M | -95.85%-2.08M |
| Income tax | 0 | 0 | 0 | -2.65M | 7.85M | 0 | 0 | -10.5M | ||
| Net income | -46.02%-15.12M | -5.38%-11.7M | -3,211.05%-12.28M | -534.06%-46.51M | -1,087.44%-24.68M | -668.82%-10.36M | -11.11M | -371K | -116.56%-7.34M | -95.85%-2.08M |
| Net income continuous Operations | -57.98%-15.12M | -18.22%-11.21M | -1,179.91%-11.83M | -410.63%-37.46M | -838.02%-19.49M | -610.62%-9.57M | ---9.49M | --1.1M | -116.56%-7.34M | -95.85%-2.08M |
| Net income discontinuous operations | --0 | 73.52%-429K | 68.55%-461K | ---9.05M | ---5.18M | ---784K | ---1.62M | ---1.47M | ---- | ---- |
| Net income extraordinary | --0 | ---61K | --2K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -46.02%-15.12M | -5.38%-11.7M | -3,211.05%-12.28M | -534.06%-46.51M | -1,087.44%-24.68M | -668.82%-10.36M | -11.11M | -371K | -116.56%-7.34M | -95.85%-2.08M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -46.02%-15.12M | -5.38%-11.7M | -3,211.05%-12.28M | -534.06%-46.51M | -1,087.44%-24.68M | -668.82%-10.36M | -11.11M | -371K | -116.37%-7.34M | -95.85%-2.08M |
| Basic earnings per share | 43.24%-0.21 | 55.00%-0.18 | -0.2 | -240.00%-1.7 | -770.00%-0.87 | -270.00%-0.37 | -0.4 | 0 | -66.67%-0.5 | 0.00%-0.1 |
| Diluted earnings per share | 43.24%-0.21 | 55.00%-0.18 | -0.2 | -240.00%-1.7 | -770.00%-0.87 | -270.00%-0.37 | -0.4 | 0 | -66.67%-0.5 | 0.00%-0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.